Loading...
In 1928, Alexander Fleming returned from vacation to find mold killing bacteria in his petri dishes. By the 1940s, penicillin was saving thousands of soldiers' lives. It seemed like humanity had won its war against infectious disease. But the war was just beginning. By the 1950s, doctors noticed something unsettling: Staphylococcus aureus infections that once yielded to penicillin were shrugging it off. The bacteria hadn't disappeared — the ones that happened to carry genetic quirks making them resistant survived each round of treatment, reproduced, and passed those quirks to their offspring. Each course of antibiotics acted as a filter, killing the susceptible and leaving behind the hardy. Within decades, methicillin-resistant Staphylococcus aureus (MRSA) was killing more Americans ann...
Popular framing: Overprescription by careless doctors caused resistance.
Structural analysis: Every dose is a selection event that filters susceptible strains and leaves resistant ones; this is evolution running on a generation time of hours. Each individual prescribing decision is rational in isolation but a tragedy-of-commons globally — the cost of resistance is paid by future patients, not this one. Pharmaceutical incentive structures make new antibiotics economically unattractive (use sparingly = small market), so the pipeline thins as resistance grows. The crisis is an incentive-evolution geometry, not negligence.
The gap matters because individual-blame framing generates interventions (awareness campaigns, prescription guidelines) that are consistently insufficient, while structural analysis suggests the system will resist reform unless incentive structures are redesigned at the level of healthcare reimbursement, agricultural regulation, international drug development funding, and global antibiotic access equity. Without closing this gap, societies repeatedly treat symptoms rather than causes.
